Toscana Virus Infections in Northern Italy: Laboratory and Clinical Evaluation
Caterina Vocale(Azienda USL di Bologna), Vittorio Sambri(Azienda Unità Sanitaria Locale Della Romagna), Paolo Gaibani(University of Verona), Claudia Giorgi(University of Florence), Maria Grazia Pascucci(Agenzia Sanitaria e Sociale Regionale), Pierluigi Viale(Azienda USL di Bologna), Francesca Cavrini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), P Macini, Giada Rossini(Azienda USL di Bologna), Andrea Tampieri(Ospedale Civile Di Ivrea), Fernanda Mori(Ospedale Infermi di Rimini), Michele Bartoletti(University of Bologna), Michele Pavoni(Ospedale Sacro Cuore Don Calabria), Tiziano Lenzi(Ospedale Civile Di Ivrea), Anna Pierro(University of Bologna), Maria Paola Landini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 20
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
2013 WSES guidelines for management of intra-abdominal infections
|World Journal of Emergency Surgery|2013|320